Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| INSEEGO CORP.INSG · Entity 7061 | Director | February 05, 2020 | May 22, 2020 |
| Tango Therapeutics, Inc.BCTG · Entity 1497 | Director | October 06, 2020 | October 07, 2020 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
INSEEGO CORP.
Report date February 05, 2020 · Filed May 22, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectSee Footnote | 71,122 |
Reported balance
After 2020-02-05 transaction · row 1
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 1 · 2020-02-05 · Grant · Acquired 11,039 · Balance 71,122 F1: Represents restricted stock units scheduled to vest on the one-year anniversary of the grant date. F2: The restricted stock units convert into common stock on a one-for-one basis. F3: Mr. Avery is obligated to transfer any shares issued pursuant to any equity awards made to him by the Issuer, or the economic benefits thereof, to Tavistock Financial, LLC. As such, the reporting person disclaims beneficial ownership of the securities reported herein, except to the extent of his pecuniary interest therein, if any. This report shall not be deemed an admission that the reporting person is a beneficial owner for the purpose of Section 16 of the Exchange Act, or for any other purpose. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents restricted stock units scheduled to vest on the one-year anniversary of the grant date.
F2: The restricted stock units convert into common stock on a one-for-one basis.
F3: Mr. Avery is obligated to transfer any shares issued pursuant to any equity awards made to him by the Issuer, or the economic benefits thereof, to Tavistock Financial, LLC. As such, the reporting person disclaims beneficial ownership of the securities reported herein, except to the extent of his pecuniary interest therein, if any. This report shall not be deemed an admission that the reporting person is a beneficial owner for the purpose of Section 16 of the Exchange Act, or for any other purpose.
Tango Therapeutics, Inc.
Report date October 06, 2020 · Filed October 07, 2020
This filing explicitly reported no securities owned.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 05, 2020 Filed May 22, 2020 20:37 UTC | INSEEGO CORP. INSG · Entity 7061 | GrantCommon Stock | 11,039 | $0.00 | $0.00 |
DisclosureSEC source: 0001683168-20-001724 · ownership.xml · nonDerivative · entry 1 Avery James B · CIK 0001747700 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 71,122 F1 · shares: Represents restricted stock units scheduled to vest on the one-year anniversary of the grant date. F2 · shares: The restricted stock units convert into common stock on a one-for-one basis. F3 · balance_after: Mr. Avery is obligated to transfer any shares issued pursuant to any equity awards made to him by the Issuer, or the economic benefits thereof, to Tavistock Financial, LLC. As such, the reporting person disclaims beneficial ownership of the securities reported herein, except to the extent of his pecuniary interest therein, if any. This report shall not be deemed an admission that the reporting person is a beneficial owner for the purpose of Section 16 of the Exchange Act, or for any other purpose. F3 · ownership.nature: Mr. Avery is obligated to transfer any shares issued pursuant to any equity awards made to him by the Issuer, or the economic benefits thereof, to Tavistock Financial, LLC. As such, the reporting person disclaims beneficial ownership of the securities reported herein, except to the extent of his pecuniary interest therein, if any. This report shall not be deemed an admission that the reporting person is a beneficial owner for the purpose of Section 16 of the Exchange Act, or for any other purpose. Read SEC document |
| February 14, 2019 Filed Feb 19, 2019 21:30 UTC | INSEEGO CORP. INSG · Entity 7061 | GrantCommon Stock | 17,562 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-19-004057 · doc4.xml · nonDerivative · entry 2 Avery James B · CIK 0001747700 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 60,083 F2 · shares: The restricted stock units convert into common stock on a one-for-one basis. F3 · shares: The restricted stock units are scheduled to vest in full on the first anniversary of the grant date. F4 · ownership.nature: Mr. Avery is obligated to transfer any shares issued pursuant to any equity awards made to him by the Issuer, or the economic benefits thereof, to Tavistock Financial LLC. As such, the reporting person disclaims beneficial ownership of the securities reported herein, except to the extent of his pecuniary interest therein, if any. This report shall not be deemed an admission that the reporting person is a beneficial owner for the purpose of Section 16 of the Exchange Act, or for any other purpose. Read SEC document |
| February 14, 2019 Filed Feb 19, 2019 21:30 UTC | INSEEGO CORP. INSG · Entity 7061 | GrantCommon Stock | 42,521 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-19-004057 · doc4.xml · nonDerivative · entry 1 Avery James B · CIK 0001747700 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 42,151 F1 · shares: The restricted stock units are scheduled to vest over a three-year period, with one-third vesting on the first anniversary of the grant date, one-third vesting on the second anniversary of the grant date and one-third vesting on the third anniversary of the grant date. F2 · shares: The restricted stock units convert into common stock on a one-for-one basis. F4 · ownership.nature: Mr. Avery is obligated to transfer any shares issued pursuant to any equity awards made to him by the Issuer, or the economic benefits thereof, to Tavistock Financial LLC. As such, the reporting person disclaims beneficial ownership of the securities reported herein, except to the extent of his pecuniary interest therein, if any. This report shall not be deemed an admission that the reporting person is a beneficial owner for the purpose of Section 16 of the Exchange Act, or for any other purpose. Read SEC document |
| February 14, 2019 Filed Feb 13, 2020 20:35 UTC Amendment | INSEEGO CORP. INSG · Entity 7061 | GrantCommon Stock | 17,562 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-20-004467 · doc4a.xml · nonDerivative · entry 2 Avery James B · CIK 0001747700 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 60,083 F2 · shares: The restricted stock units convert into common stock on a one-for-one basis. F3 · shares: The restricted stock units are scheduled to vest in full on July 1, 2020. F5 · shares: Mr. Avery is filing this amendment to reflect the amended vesting schedules for the grants of restricted stock units. F4 · ownership.nature: Mr. Avery is obligated to transfer any shares issued pursuant to any equity awards made to him by the Issuer, or the economic benefits thereof, to Tavistock Financial, LLC. As such, the reporting person disclaims beneficial ownership of the securities reported herein, except to the extent of his pecuniary interest therein, if any. This report shall not be deemed an admission that the reporting person is a beneficial owner for the purpose of Section 16 of the Exchange Act, or for any other purpose. Read SEC document |
| February 14, 2019 Filed Feb 13, 2020 20:35 UTC Amendment | INSEEGO CORP. INSG · Entity 7061 | GrantCommon Stock | 42,521 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-20-004467 · doc4a.xml · nonDerivative · entry 1 Avery James B · CIK 0001747700 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 42,521 F1 · shares: The restricted stock units are scheduled to vest over a three-year period, with one-third vesting on July 1, 2020, one-third vesting on October 25, 2020 and one-third vesting on October 25, 2021. F2 · shares: The restricted stock units convert into common stock on a one-for-one basis. F5 · shares: Mr. Avery is filing this amendment to reflect the amended vesting schedules for the grants of restricted stock units. F4 · ownership.nature: Mr. Avery is obligated to transfer any shares issued pursuant to any equity awards made to him by the Issuer, or the economic benefits thereof, to Tavistock Financial, LLC. As such, the reporting person disclaims beneficial ownership of the securities reported herein, except to the extent of his pecuniary interest therein, if any. This report shall not be deemed an admission that the reporting person is a beneficial owner for the purpose of Section 16 of the Exchange Act, or for any other purpose. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.